IR-101

· Sichuan University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IR-101, covering 2025-07-29 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma [EARLY_Phase 1]